Abstract
It has been suggested that immunosuppression with cyclosporine induces marked sympathetic neural hyperactivity in heart transplant recipients. In the present study, the resting level of sympathetic nerve activity was investigated with intraneural recording in nine patients with severe chronic heart failure (NYHA class III-IV despite ongoing therapy), in nine heart-transplanted patients with previous heart failure (NYHA class III-IV) receiving standard low-dose triple-drug immunosuppression and in six age-matched controls without cardiovascular disease. Compared to the control group, resting sympathetic nerve discharge was markedly increased in heart failure patients (92 +/- 2 vs 60 +/- 6 B/100 b, P < 0.01), sympathetic nerve activity was lower in the majority of heart failure patients after heart transplantation, and mean burst incidence was significantly lower than in the cardiac failure group (70 +/- 7, P < 0.01). The difference between transplanted patients and the control group was not statistically significant. Thus, heart transplant recipients may reduce the augmented central sympathetic drive associated with cardiac failure despite ongoing cyclosporine treatment.
Citations
Jun 5, 1998·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Y B SverrisdóttirM Elam
Jun 15, 2005·Life Sciences·Flávio ReisFrederico Teixeira
Mar 1, 1997·Journal of Cardiac Failure·B RundqvistM Elam
Sep 1, 1996·Heart & Lung : the Journal of Critical Care·L V DoeringC T Peter
Nov 26, 1999·Nursing Research·L V DoeringC T Peter
Jul 9, 2002·Clinical Endocrinology·Roland W McCallumJohn M C Connell
Oct 20, 1999·Circulation·V G MacefieldM Elam
Mar 30, 1999·Circulation·P van de BorneV K Somers
Mar 30, 2005·Hypertension·Agnieszka CiarkaPhilippe van de Borne
May 1, 1994·Hypertension·T LysonR G Victor
Oct 25, 2000·Circulation·Y B SverrisdóttirM Elam
Jul 1, 1997·Circulation·A MortaraL Tavazzi
Oct 10, 2001·Circulation·P van De BorneJ P Degaute
Jun 17, 1998·The Journal of Clinical Endocrinology and Metabolism·Y B SverrisdóttirG Johannsson
Apr 6, 2019·Journal of Hypertension·Guido GrassiCarmine Zoccali